bpc 157 oral bioavailability studies BPC-157 Most peptides aren’t orally bioavailable

[DOI] [PubMed] [Google Scholar] 114.Hao H, Bao F, Wang Y, Li N, Gong Y

The standard regimen involves: Loading doses without neurological involvement : 1 mg intramuscularly three times a week for 2 weeks [3] [8] Loading doses with neurological involvement : 1 mg intramuscularly on alternate days until no further improvement [3] [8] Maintenance therapy : 1 mg every 23 months for life in cases of pernicious anaemia or irreversible malabsorption (every 2 months if neurological involvement) [3] [8] This aggressive approach aims to prevent irreversible neurological damage, though recovery of established neuropathy may be incomplete, particularly if treatment is delayed

Confirm the endpoint before first use The vial is ready only when the solution looks uniform and free of visible undissolved material

Therefore, there is still the need for the discovery and/or development of a drug candidate characterized by at least a comparable pain-relieving effect to opioids but with a much better safety prole in terms of expected adverse reactions

Each community has its own specific guidelines for safe disposal, so its important to follow your local regulations